Assessing mRNA and LNP Quality Attributes and Impurities
Detailed and sensitive characterization of ionizable lipids that make up lipid nanoparticles (LNP) and their related impurities is necessary to ensure the quality of mRNA therapies. Additionally, there are mRNA quality attributes such as 5’ capping that directly impact efficacy and safety.
Watch this webinar to see real-time instrument operation, sample analysis, and data processing and learn more about:
- Key workflows for the analysis of mRNA therapies
- mRNA structural characterization
- 5’-capping process
Matt Stone, PhD
Biologics Workflow Specialist SCIEX